$CUE

1 thesis
bullish 0%neutral 0%bearish 100%
Avg return (6m)
Win rate (6m)
(0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$CUESEC Form 4bearish
Sold 58,258 @ $27.58 avg · $1,606,562 · 2026-08-12

Form 4: Lin Shao-Lee sold CUE

Lin Shao-Lee (Chief Executive Officer at Cue Biopharma, Inc.) reported an open-market sale of 58,258 shares of CUE at an average $27.58, roughly $1,606,562, in a Form 4 filed 2026-08-14.

View filing on SEC.gov →

End of results.